Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer
Swiss Cancer Institute
Swiss Cancer Institute
Virginia Commonwealth University
Singapore General Hospital
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
NYU Langone Health
UNC Lineberger Comprehensive Cancer Center